Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page, with no evident changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:28:39.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The Locations section is reorganized into a consolidated 'Locations' block with added provinces (Beijing Municipality, Hebei, Heilongjiang, Hunan, Jilin, Shanxi, Sichuan), replacing the former province-specific location headings. The revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T20:25:32.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. This update appears to be a metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2025-11-24T21:29:19.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The general government funding status notice related to NIH operations has been removed, but this does not affect the study details, eligibility, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T19:22:45.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The update appears to be limited to minor layout and formatting adjustments on the study page; core details like inclusion criteria, outcomes, and participating sites remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:04.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T04:14:51.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.